Younhee Cho Aleksandra Baranczak Stephen Helmke Sergio Teruya Evelyn M Horn Mathew S Maurer Jeffery W Kelly
10.3109/13506129.2015.1063485
Amyloid
2015;22(3):175-80.
senile systemic amyloidosis vyndaqel wild-type ttr amyloid cardiomyopathy
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/26193961/
Amyloid Neuropathies, Familial / blood Benzoxazoles / blood Cardiomyopathies / blood Neuroprotective Agents / blood Prealbumin / chemistry
Amyloid Neuropathies, Familial / blood Benzoxazoles / blood Cardiomyopathies / blood Neuroprotective Agents / blood Prealbumin / chemistry Case Reports Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Aged, 80 and over Amyloid Neuropathies, Familial / complications Amyloid Neuropathies, Familial / drug therapy Amyloid Neuropathies, Familial / pathology Benzoxazoles / pharmacokinetics Benzoxazoles / pharmacology Cardiomyopathies / complications Cardiomyopathies / drug therapy Cardiomyopathies / pathology Drug Dosage Calculations Drug Monitoring Escherichia coli / genetics Escherichia coli / metabolism Gene Expression Humans Kinetics Male Neuroprotective Agents / pharmacokinetics Neuroprotective Agents / pharmacology Prealbumin / analysis Prealbumin / metabolism Precision Medicine Protein Stability / drug effects Recombinant Proteins / analysis Recombinant Proteins / chemistry Recombinant Proteins / metabolism Benzoxazoles Neuroprotective Agents Prealbumin Recombinant Proteins tafamidis Amyloidosis, Hereditary, Transthyretin-Related
PMC4549186
26193961
Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy)
2015